Skip to content

study of varuna Kwatha and Kanchnara Triphala Kwatha in the management of thyroid disorder

A COMPARATIVE CLINICAL EVALUATION OF â??VARUNA KWATHAâ?? AND â??KANCHNARA TRIPHALA KWATHAâ?? IN THE MANAGEMENT OF DHATVAGNIMANDHYA W.S.R. TO HYPOTHYROIDISM

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/024124
Enrollment
30
Registered
2020-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified

Interventions

Intervention1: VARUNA KWATHA KANCHNARA TRIPHALA KWATHA: There will be 2 groups: 1. Group A: Varuna Kwatha will be given to 15 patients in dose of 40 ml twice in a day (in morning & evening) for 30 day

Sponsors

National Institute Of AyurvedaJaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A subject will be eligible for inclusion in this study only if all of the following criteria applied: 1. Patients between the ages of 18-60 years of either sex. 2. Patients who are newly diagnosed or mild case of hypothyroidism with increased TSH levels(more than 5.5µIU/ml& less than 30µIU/ml) 3. Patients who are ready to switch over to ayurvedic medicine and have sign the consent form. 4. Patients who are already diagnosed as hypothyroidism and under Levo-thyroxine medication but still presenting with the increased TSH level.

Exclusion criteria

Exclusion criteria: A subject will not be eligible for inclusion in this study if any of the following criteria applied: 1. Patients suffering from congenital hypothyroidism and secondary hypothyroidism. 2. Pregnant women, hyperthyroidism, neoplasia, toxic goitre are excluded. 3. Patients who have under gone any type of thyroid surgery. 4. Patients whose symptoms are worsely aggravated after leaving the modern drug Levo-thyroxine (for washout period of 1 month). 5. Mentally ill/ retarded patients. 6. Drug induced hypothyroidism.

Design outcomes

Primary

MeasureTime frame
Change in Thyroid profile.Timepoint: 0th and 30th day

Secondary

MeasureTime frame
Change in Qualitative variable. Change in BMI index. Timepoint: 0th and 30th day

Countries

India

Contacts

Public ContactDr Ajay kumar Sahu

National Institute of Ayurveda,Jaipur

drajaysahu@gmail.com9950708106

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026